Cargando…

Differential microglia and macrophage profiles in human IDH-mutant and -wild type glioblastoma

Microglia and macrophages are the largest component of the inflammatory infiltrate in glioblastoma (GBM). However, whether there are differences in their representation and activity in the prognostically-favorable isocitrate dehydrogenase (IDH)-mutated compared to -wild type GBMs is unknown. Studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poon, Candice C., Gordon, Paul M.K., Liu, Katherine, Yang, Runze, Sarkar, Susobhan, Mirzaei, Reza, Ahmad, Shiekh Tanveer, Hughes, Martha L., Yong, V. Wee, Kelly, John J.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517100/ https://www.ncbi.nlm.nih.gov/pubmed/31139325 http://dx.doi.org/10.18632/oncotarget.26863

Ejemplares similares

Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity
por: Sarkar, Susobhan, et al.
Publicado: (2018)

The battle for the brain: Brain tumor-initiating cells vs. microglia/macrophages
por: Sarkar, Susobhan, et al.
Publicado: (2014)

Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma
por: Richardson, Timothy E, et al.
Publicado: (2023)

Molecular landscape of IDH ‐wild type, pTERT ‐wild type adult glioblastomas
por: Liu, Emma Munan, et al.
Publicado: (2022)

Deep Learning Can Differentiate IDH-Mutant from IDH-Wild GBM
por: Pasquini, Luca, et al.
Publicado: (2021)

MRI-Based Radiomics Combined with Deep Learning for Distinguishing IDH-Mutant WHO Grade 4 Astrocytomas from IDH-Wild-Type Glioblastomas
por: Hosseini, Seyyed Ali, et al.
Publicado: (2023)

In Vivo MR Imaging of Tumor-Associated Macrophages: The Next Frontier in Cancer Imaging
por: Yang, Runze, et al.
Publicado: (2018)

Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells
por: Fan, Dandan, et al.
Publicado: (2021)

Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor‐initiating cells
por: Dzikowski, Lauren, et al.
Publicado: (2021)

Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma()()
por: Sun, Chao, et al.
Publicado: (2020)

Demeclocycline Reduces the Growth of Human Brain Tumor-Initiating Cells: Direct Activity and Through Monocytes
por: Sarkar, Susobhan, et al.
Publicado: (2020)

The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma
por: Javier, Rodrigo, et al.
Publicado: (2022)

GEN-10 WHOLE GENOME LANDSCAPE OF GLIOBLASTOMA, IDH-WILD TYPE
por: Nakashima, Takuma, et al.
Publicado: (2022)

Implications of Cellular Immaturity in Necrosis and Microvascularization in Glioblastomas IDH-Wild-Type
por: Orasanu, Cristian Ionut, et al.
Publicado: (2022)

Molecular classification of IDH-mutant glioblastomas based on gene expression profiles
por: Wu, Fan, et al.
Publicado: (2019)

DNMT3A co-mutation in an IDH1-mutant glioblastoma
por: Fomchenko, Elena I., et al.
Publicado: (2019)

Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma
por: Thimma Sudarsan, Rishan, et al.
Publicado: (2022)

Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
por: Blanco-Carmona, Enrique, et al.
Publicado: (2023)

Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks
por: Li, Kay Ka-Wai, et al.
Publicado: (2019)

Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2020)

The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation
por: Marchi, Francesco, et al.
Publicado: (2020)

The Prognostic Value of NANO Scale Assessment in IDH-Wild-Type Glioblastoma Patients
por: Kasper, Johannes, et al.
Publicado: (2021)

Prognostic analysis and nomogram construction for older patients with IDH-wild-type glioblastoma
por: Cao, Wenjun, et al.
Publicado: (2023)

Energy Metabolism in IDH1 Wild-Type and IDH1-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy?
por: van Noorden, Cornelis J.F., et al.
Publicado: (2021)

Immuno-phenotyping of IDH-mutant grade 3 astrocytoma and IDH-wildtype glioblastoma reveals specific differences in cells of myeloid origin
por: Raghavan, Jayashree V., et al.
Publicado: (2021)

Mismatch repair–deficient glioma with spatially distinct IDH-mutant and IDH-wild type components arising in the setting of Lynch syndrome
por: Tan, Hao, et al.
Publicado: (2023)

Whole genome duplication is an early event leading to aneuploidy in IDH-wild type glioblastoma
por: Boisselier, Blandine, et al.
Publicado: (2018)

Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma
por: Bagley, Stephen J, et al.
Publicado: (2021)

Phosphorous Magnetic Resonance Spectroscopy and Molecular Markers in IDH1 Wild Type Glioblastoma
por: Galijašević, Malik, et al.
Publicado: (2021)

The Role of EGFR Amplification in Deep Venous Thrombosis Occurrence in IDH Wild-Type Glioblastoma
por: Kaye, Brandon, et al.
Publicado: (2023)

MYEF2: an immune infiltration-related prognostic factor in IDH-wild-type glioblastoma
por: Zhang, Yunxiao, et al.
Publicado: (2023)

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia
por: Wang, Tao, et al.
Publicado: (2023)

Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
por: Chai, Ruichao, et al.
Publicado: (2021)

Updates in IDH-Wildtype Glioblastoma
por: Melhem, Jawad M., et al.
Publicado: (2022)

Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)

Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers
por: Unruh, Dusten, et al.
Publicado: (2019)

Postoperative risk of IDH-mutant glioma–associated seizures and their potential management with IDH-mutant inhibitors
por: Drumm, Michael R., et al.
Publicado: (2023)

Integrative transcriptome analysis identified a BMP signaling pathway-regulated lncRNA AC068643.1 in IDH mutant and wild-type glioblastomas
por: Huang, Guo-Hao, et al.
Publicado: (2020)

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma()()
por: Stasik, Sebastian, et al.
Publicado: (2020)

Mutations and Copy Number Alterations in IDH Wild-Type Glioblastomas Are Shaped by Different Oncogenic Mechanisms
por: Ülgen, Ege, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r9tjlil6vtjfqsvq61av8s9j5e